Buy TB-500 Online | The A-Z Guide

Now that we know what TB-500 is, let’s dig into the potential benefits of this research peptide.

While Thymosin Beta-4 is not approved by the FDA, several published studies have examined the effects it has in animals and human test subjects.

Here’s an in-depth look at some of the TB-500 benefits shown in past studies:

Thymosin Beta-4 may promote wound healing and repair

TB-500 has displayed healing properties in past animal studies. For instance, one study in 2007 involving mice with deep skin wounds discovered that Thymosin Beta-4 promoted complete healing of the wounds [3].

Another review published in the same year examined Thymosin Beta-4 for its ability to heal eye wounds [4]. This is especially important as the cells must connect to the underlying connective tissue for complete healing to take place.

Seven years later, in 2014, another study was released that demonstrated Thymosin Beta-4’s viability for treating burn wounds [5].

The findings from these studies indicate that TB-500 may promote wound healing and repair, suggesting that further research appears warranted.

Thymosin Beta-4 may help repair heart damage

As early as 2007, scientists were already investigating Thymosin Beta-4 for its potential in treating ischemic heart disease.

Specifically, the research team at RegeneRx Biopharmaceuticals was creating a Thymosin Beta-4 formulation for use in patients with acute myocardial infarction.

And they did so because Thymosin Beta-4 demonstrated the following cardiovascular benefits [6]:

• Plays an essential role in all key stages of cardiac vessel development
• Promotes migration and survival migration of cardiomyocytes (responsible for generating the force needed to help the heart beat in an even rhythm)

Since then, Thymosin Beta-4 has been shown to protect mice from pulmonary hypertension, which causes the right ventricle of the heart to work “harder” until it eventually fails [7].

TB-500 effect on every single aspect of cardiac repair – tissue regeneration, cardioprotection, inflammation - is still being examined to this day [8].

Thymosin Beta-4 may offer anti-inflammatory properties

Thymosin Beta-4 is a promising agent for treating chronic levels of inflammation, targeting both anti-inflammatory and pro-inflammatory cells [9]:

“[Thymosin Beta-4] not only down-regulates inflammatory mediators but also up-regulates pre-inflammatory cytokine suppressors, such as interleukin-10, and reduces the infiltration and adhesion of inflammatory cells”

This finding was also confirmed in a 2007 study where Thymosin Beta-4 reduced the activity of NFκB, a known pro-inflammatory compound that tends to be active in the inflammation of the cornea [10].

But this discovery is not final, as rheumatoid arthritis researchers are uncertain whether higher levels of Thymosin Beta-4 act in a pro-inflammatory or anti-inflammatory manner [11].

Thymosin Beta-4 may treat traumatic brain injury (TBI)

An interesting rat study published in 2011 looked at rats with TBI to see if Thymosin Beta-4 offered any neuroprotective effects.

Not only did Thymosin Beta-4 lead to reduced cell loss in the hippocampus, but it also stimulated the growth of new blood vessels and neuronal cells in the damaged areas [12].

As a bonus, Thymosin Beta-4 also helped improve spatial learning and accelerated the functional recovery of sensory-motor skills!

Thymosin Beta-4 may serve as a vital biomarker for several diseases

According to a 2018 review, Thymosin Beta-4 is already being examined for its use as a way to identify the presence and progression of various diseases [13]:

“…plasma TB4 correlates with symptomatic improvements after cardiac cell therapy, predicts mortality in female heart failure, is lowered in serum after heart attack, and elevated in rheumatoid arthritis.

There is also a pending patent to use TB4 as part of a biomarker panel for diagnosing and directing treatment of sepsis.”

Thymosin Beta-4 demonstrates phenomenal therapeutic potential, both as a treatment and as a way to identify biological diseases before they get worse.

While TB-500 research is still in its infancy, many researchers are actively exploring its potential benefits. In the following section, we will explore the best way for researchers to obtain TB-500 for experiments.